Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | lanosterol synthase | 0.0644 | 1 | 1 |
Echinococcus granulosus | ras gtpase | 0.06 | 0.893 | 1 |
Trichomonas vaginalis | rheb, putative | 0.06 | 0.893 | 1 |
Trichomonas vaginalis | ral, putative | 0.06 | 0.893 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.06 | 0.893 | 1 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.06 | 0.893 | 1 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0587 | 0.8607 | 1 |
Trichomonas vaginalis | dexras1, putative | 0.06 | 0.893 | 1 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0587 | 0.8607 | 0.5 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0644 | 1 | 1 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0587 | 0.8607 | 0.5 |
Trichomonas vaginalis | rap1 and, putative | 0.06 | 0.893 | 1 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0587 | 0.8607 | 0.8607 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.06 | 0.893 | 1 |
Echinococcus multilocularis | ras gtpase | 0.06 | 0.893 | 1 |
Entamoeba histolytica | Ras family GTPase | 0.06 | 0.893 | 1 |
Loa Loa (eye worm) | Ras protein let-60 | 0.06 | 0.893 | 1 |
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0587 | 0.8607 | 0.5 |
Entamoeba histolytica | ras-1, putative | 0.06 | 0.893 | 1 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0587 | 0.8607 | 0.8607 |
Entamoeba histolytica | Ras family GTPase | 0.06 | 0.893 | 1 |
Leishmania major | farnesyltransferase beta subunit | 0.0587 | 0.8607 | 1 |
Brugia malayi | Ras protein let-60 | 0.06 | 0.893 | 1 |
Brugia malayi | Ras-related protein R-Ras2 | 0.06 | 0.893 | 1 |
Giardia lamblia | Prenyltransferase | 0.0587 | 0.8607 | 0.5 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0644 | 1 | 1 |
Entamoeba histolytica | protein farnesyltransferase beta subunit, putative | 0.0587 | 0.8607 | 0.9639 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.